Kaddouri, Y.; Bouchal, B.; Abrigach, F.; El Kodadi, M.; Bellaoui, M.; Elkamhawy, A.; Touzani, R.; Abdellattif, M.H.
New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties. Pharmaceuticals 2022, 15, 803.
https://doi.org/10.3390/ph15070803
AMA Style
Kaddouri Y, Bouchal B, Abrigach F, El Kodadi M, Bellaoui M, Elkamhawy A, Touzani R, Abdellattif MH.
New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties. Pharmaceuticals. 2022; 15(7):803.
https://doi.org/10.3390/ph15070803
Chicago/Turabian Style
Kaddouri, Yassine, Btissam Bouchal, Farid Abrigach, Mohamed El Kodadi, Mohammed Bellaoui, Ahmed Elkamhawy, Rachid Touzani, and Magda H. Abdellattif.
2022. "New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties" Pharmaceuticals 15, no. 7: 803.
https://doi.org/10.3390/ph15070803
APA Style
Kaddouri, Y., Bouchal, B., Abrigach, F., El Kodadi, M., Bellaoui, M., Elkamhawy, A., Touzani, R., & Abdellattif, M. H.
(2022). New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties. Pharmaceuticals, 15(7), 803.
https://doi.org/10.3390/ph15070803